Krishnan Palaniappan

Title: Innovations of Krishnan Palaniappan in Proteomics

Introduction

Krishnan Palaniappan is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of proteomics through his innovative work in artificial neural networks. With a total of 2 patents, Palaniappan is recognized for his advancements in predicting amino acid sequences and mass spectrometry data.

Latest Patents

Palaniappan's latest patents include two groundbreaking inventions. The first patent, titled "Artificial neural network models for prediction of de novo sequencing of chains of amino acids," focuses on techniques for predicting the sequencing of peptides and proteins. This invention utilizes a computer-implemented method that involves obtaining a digital representation of a mass spectrum and employing a bidirectional recurrent neural network to decode encoded vectors into a sequence of amino acids.

The second patent, "Artificial neural network model for prediction of mass spectrometry data of peptides or proteins," also addresses proteomics. This invention involves a method for predicting mass spectrometry data of amino acid chains. It includes obtaining a digital representation of a peptide sequence and encoding each container element as an encoded vector, which is then decoded into a theoretical output spectrum.

Career Highlights

Krishnan Palaniappan is currently employed at Verily Life Sciences LLC, where he continues to push the boundaries of research in proteomics. His work has garnered attention for its innovative approach to utilizing artificial intelligence in biological research.

Collaborations

Palaniappan has collaborated with notable colleagues, including Peter Cimermancic and Roie Levy. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Krishnan Palaniappan's contributions to the field of proteomics through his innovative patents highlight the intersection of artificial intelligence and biological research. His work continues to pave the way for advancements in understanding amino acid sequencing and mass spectrometry data.